Proof-of-Concept and Dose Range-Finding Study of SCH 527123 in Subjects with Severe Asthma

Registry ID

EUCTR2008-004119-36

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Schering-Plough Research Institute

Start date

2010-01-12

Completion date

2010-01-09

Last update

2026-08-16

Conditions

• Severe Asthma

Summary

The primary objective of this study is to assess the effect of SCH 527123 on severe asthma exacerbations in subjects with severe asthma.

Locations

• , , Germany
• , , Hungary
• , , UK

Related clinical trials

• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
• Physical Activity Promotion and Clinical Remission in Severe Asthma
• A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
• Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes
• Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)

View on source registry